BRIEF published on 07/04/2025 at 07:05, 10 months 7 days ago Innate Pharma annonce une mise à jour de ses actions et de ses droits de vote Euronext Actions Nasdaq Droit De Vote Innate Pharma
BRIEF published on 07/04/2025 at 07:05, 10 months 7 days ago Innate Pharma Announces Share and Voting Rights Update Voting Rights Shares Euronext Nasdaq Innate Pharma
PRESS RELEASE published on 07/04/2025 at 07:00, 10 months 7 days ago Inside Information / Other news releases Innate Pharma discloses number of shares and voting rights as of July 3, 2025, in accordance with French regulations. Total shares: 92,183,523. Total voting rights: 92,962,943 (theoretical) and 92,944,368 (exercisable) Voting Rights Shares French Regulations Financial Disclosure Innate Pharma
BRIEF published on 06/17/2025 at 07:05, 10 months 24 days ago Innate Pharma participera à des conférences d'investisseurs clés Biotechnologie Immunothérapie Soins De Santé Conférences D'investisseurs Innate Pharma
BRIEF published on 06/17/2025 at 07:05, 10 months 24 days ago Innate Pharma to Participate in Key Investor Conferences Biotechnology Investor Conferences Healthcare Immunotherapy Innate Pharma
PRESS RELEASE published on 06/17/2025 at 07:00, 10 months 24 days ago Inside Information / Other news releases Innate Pharma to participate in H.C. Wainwright and Wolfe Research healthcare conferences showcasing their innovative immunotherapy approaches. Global biotech company expanding portfolio Biotechnology Immunotherapy Clinical-stage Innate Pharma Healthcare Conferences
BRIEF published on 06/13/2025 at 07:05, 10 months 28 days ago Innate Pharma's IPH6501 Shows Potential in Lymphoma Treatment Innate Pharma Preclinical Results IPH6501 Lymphoma R-CHOP
BRIEF published on 06/13/2025 at 07:05, 10 months 28 days ago L'IPH6501 d'Innate Pharma montre un potentiel dans le traitement du lymphome Innate Pharma Résultats Précliniques IPH6501 R-CHOP Lymphome
PRESS RELEASE published on 06/13/2025 at 07:00, 10 months 28 days ago Inside Information / Other news releases Innate Pharma highlights preclinical antitumor activity of IPH6501 in DLBCL and FL at the 2025 EHA Congress, presenting potent efficacy in in vitro and in vivo models with R-CHOP combination Preclinical Data EHA Congress Innate Pharma Antitumor Activity IPH6501
BRIEF published on 05/13/2025 at 07:05, 11 months 29 days ago Innate Pharma publie ses résultats du premier trimestre 2025 Résultats Financiers Essais Cliniques Innate Pharma Investissement Sanofi Lacutamab FDA
Published on 05/11/2026 at 14:30, 3 hours 34 minutes ago Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides
Published on 05/11/2026 at 14:00, 4 hours 4 minutes ago Unusual Machines Accelerates Domestic Battery Manufacturing by Signing a Merger Agreement to Acquire Upgrade Energy
Published on 05/11/2026 at 14:00, 4 hours 4 minutes ago New Horizon Aircraft Ltd. Announces Closing of $20 Million Offering of Common Shares
Published on 05/11/2026 at 14:00, 4 hours 4 minutes ago Colosseum Bankable Feasibility Study Confirms High Margin Gold Project
Published on 05/11/2026 at 14:00, 4 hours 4 minutes ago Ur-Energy Reminds Shareholders and Interested Parties of First Quarter Conference Call and Webcast
Published on 05/11/2026 at 17:53, 10 minutes ago EQS-Adhoc: EnviTec Biogas issues forecast: Subdued earnings development in the current fiscal year 2026, top-line and earnings growth in 2027; Suspension of dividend for 2025 proposed
Published on 05/11/2026 at 17:48, 15 minutes ago Elmos Semiconductor SE: Placement of existing shares by two major Elmos shareholders via accelerated bookbuilding
Published on 05/11/2026 at 17:40, 23 minutes ago EQS-Adhoc: Elmos Semiconductor SE: Placement of existing shares by two major Elmos shareholders via accelerated bookbuilding
Published on 05/11/2026 at 17:40, 24 minutes ago VALBIOTIS SA: Valbiotis continues its expansion in Asia
Published on 05/11/2026 at 18:00, 4 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 avril 2026
Published on 05/11/2026 at 17:47, 16 minutes ago Déclaration des transactions sur actions propres réalisées du 04/05/2026 au 10/05/2026
Published on 05/11/2026 at 17:45, 19 minutes ago Annule et remplace : Informations relatives au nombre total de droits de vote et d’actions
